Fundraising Fox
Aukera Therapeutics GmbH
Basel, CH · 1 known investors
Find your way into Aukera Therapeutics GmbH
Sign up to find every way you can get introduced to Aukera Therapeutics GmbH
- Your email: who you already know at Aukera Therapeutics GmbH, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Aukera Therapeutics GmbH team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Aukera Therapeutics is a preclinical-stage biotech company, spun out of the University of Basel's Biozentrum, developing the first RAPTOR inhibitors to treat mTORC1-related diseases. It pairs mTOR pathway expertise with an AI-driven drug discovery engine aimed at complex, hard-to-drug targets.
Founders & leadership
ST
Stefan Thomas ImsengManaging Director
Investors · 1
Frequently asked questions
- What does Aukera Therapeutics GmbH do?
- Aukera Therapeutics is a preclinical-stage biotech company, spun out of the University of Basel's Biozentrum, developing the first RAPTOR inhibitors to treat mTORC1-related diseases. It pairs mTOR pathway expertise with an AI-driven drug discovery engine aimed at complex, hard-to-drug targets.
- Who founded Aukera Therapeutics GmbH?
- Aukera Therapeutics GmbH was founded by Stefan Thomas Imseng.
- Who are Aukera Therapeutics GmbH's investors?
- Aukera Therapeutics GmbH's investors include Kickfund.
- Where is Aukera Therapeutics GmbH headquartered?
- Aukera Therapeutics GmbH is headquartered in Basel, CH.